CN1965888A - Chinese medicinal composition for treating breast cancer - Google Patents
Chinese medicinal composition for treating breast cancer Download PDFInfo
- Publication number
- CN1965888A CN1965888A CN 200510125223 CN200510125223A CN1965888A CN 1965888 A CN1965888 A CN 1965888A CN 200510125223 CN200510125223 CN 200510125223 CN 200510125223 A CN200510125223 A CN 200510125223A CN 1965888 A CN1965888 A CN 1965888A
- Authority
- CN
- China
- Prior art keywords
- parts
- processed
- chinese medicine
- myrrha
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating mammary cancer, which is prepared from Chinese angelica root, pericarpium trichosanthis, licorice root, frankincense and myrrh by a predetermined proportions. The medicament can be prepared into any of the conventional dosage forms.
Description
Technical field: the invention discloses a kind of Chinese medicine composition for the treatment of breast carcinoma, relate to the field of Chinese medicines.
Background technology: breast carcinoma is a kind of women Chang Fa disease, generally is meant the malignant tumor that betides lobules of mammary gland and ductal epithelium.In China, breast cancer incidence just obviously increased from 30 years old, with 40 years old-60 years old served as maximum, account for 75%, the sickness rate of breast carcinoma is in rising trend these years, because should disease belong to the endocrine dependent tumors, main treatment means has excision, radiotherapy, endocrine therapy and chemotherapy, main at present employing hormone therapy can make patient obtain than remarkable result, especially adopt prevailing be antiestrogen such as tamoxifen, amino is led to sleep and is added the hydrogenation prednisone in addition, the chemotherapy that then adopts that has is eliminated cancerous cell or clinical foci in the blood circulation, and chemotherapeutics commonly used has tamoxifen, amycin, cyclophosphamide, mitomycin etc.Have on the traditional Chinese medical science and adopt the part Chinese patent medicine to carry out auxiliary treatment, XIAOJIN DAN, Xi Huan Wan, awake disappear ball, eliminating stagnation spirit etc. are wherein arranged comparatively widely, main activating blood circulation to dissipate blood stasis, the detoxifcation pain that disappears that plays acts on, other has this disease of treatment by Chinese herbs is to utilize 200310109412 patent drug and preparation method, mainly be that breast carcinoma with estrogen receptor negative provides and prevents the medicine that recurs and shift, but adopt the general toxic side effect of these treatment meanss at present, the Chinese patent medicine weak curative effect is unsatisfactory.Therefore market is needed a kind of do not have toxic and side effects and Chinese medicine composition evident in efficacy badly.
Summary of the invention: the purpose of this invention is to provide a kind of radical cure breast carcinoma that has, make it to reach hard masses softening and resolving, blood stasis dispelling detoxifcation, Chinese medicine composition with low cost.
Medicine of the present invention is through several generations' clinical research, up to now, do not find the medicine better than the present invention curative effect of medication, that cost is low, and through a large amount of clinical comparison and experiment, finally find the oral medicinal herb medicine composition that better curative effect treatment breast carcinoma is arranged, thereby finished the present invention.
Medicament selection Radix Angelicae Sinensis of the present invention, complete old Fructus Trichosanthis, Radix Glycyrrhizae, Olibanum (processed), Myrrha (processed) make up, and make each medicine effect produce synergism these drug regimens, thereby can effectively effect a radical cure the recurrence of breast carcinoma and disease thereof.Wherein select Radix Angelicae Sinensis all wind and cold of dispelling for use, mend all blood deficiency, mend the function of all strains, can control many skin infection, carbuncle, evacuation of pus pain relieving, and can break stagnant blood, grow fresh blood, the many discomforts of female body all can be used, and pass through wine especially
The Radix Angelicae Sinensis drug effect of crossing is better.Radix Glycyrrhizae can be controlled severe palpitation, the irregularly intermittent and regularly intermittent pulse of Qi and blood deficiency, can play invigorating the spleen and replenishing QI deficiency of spleen-QI and stomach-QI disease, heat-clearing and toxic substances removing, skin sore, relaxes the property of medicine, is in harmonious proportion hundred medicines.Complete old Fructus Trichosanthis can activating blood circulation to dissipate blood stasis, pleasant reason is smooth, particularly follows above all medicine compatibilities, and effect is better.Olibanum (processed) can regulating qi and activating blood, analgesic therapy, broken poison, treatment coagulation of QI-blood, trusted subordinate's pain, swollen ulcer drug, traumatic injury, dysmenorrhea, congestion twinge in puerperal, and Myrrha (processed) is also had regulating qi and activating blood, analgesic therapy, broken poison, the blood clotting of venting one's spleen stagnates, the pain skin ulcer swells and ache a function.
In order to obtain optimum curative effect, the present invention also can add yellow wine on the basis of said medicine, and this is because behind said composition and the yellow wine compatibility, can help all medicines better to bring into play drug effect, reaches optimum therapeuticing effect.
The amounts of components of medicine of the present invention also gropes to sum up to draw through the inventor in a large number, and each amounts of components is for all to have better curative effect in the following weight parts scope:
The complete old Fructus Trichosanthis 20-30 part of Radix Angelicae Sinensis 20-30 part Radix Glycyrrhizae 20-30 part
Olibanum (processed) 10-20 part Myrrha (processed) 10-20 part
Be preferably:
25 parts of 25 parts of complete old Fructus Trichosanthis of 25 parts of Radix Glycyrrhizae of Radix Angelicae Sinensis
15 parts of 15 parts of Myrrha (processed)s of Olibanum (processed)
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, to select medicine for use be raw material for the natural edible-plant medicine in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment breast carcinoma of the Chinese medicine of respectively distinguishing the flavor of, and do not have chemical sweeting agent, nontoxic to human body.
2, the present invention makes simply, and is with low cost, reduced patient's treatment cost significantly.
3, curative effect height, cure rate can reach more than 85%, and one need not perform the operation, and two without chemotherapy, and three without radiotherapy, four hospitalization not.
4, medicine of the present invention also can with the supporting use of other western medical treatment, curative effect is better.
Embodiment:
Press following proportioning (part) weighting raw materials:
25 parts of 25 parts of complete old Fructus Trichosanthis of 25 parts of Radix Glycyrrhizae of Radix Angelicae Sinensis
15 parts of 15 parts of Myrrha (processed)s of Olibanum (processed)
Production method is as follows:
1, above crude drug is ground into coarser powder.
2, put into pot with the yellow wine of 15 times of weight portions of above crude drug gross weight, little fire boils half weight portion and gets final product decoction being taken warmly.
3, also can be broken into smalls to Fructus Trichosanthis, Radix Angelicae Sinensis, Radix Glycyrrhizae powder, the suitable yellow wine of reuse melts with the Olibanum Myrrha and lives into as the big piller of Bowl bean, takes after mixing it with water with yellow wine behind the airing.
4, become as breast carcinoma poison, can suppurate after taking medicine is water, and malicious end becomes then internal diabetes, and disease very person can serve on several doses, and the lighter 1-2 agent is with the degree of being of healing.
Claims (4)
1, a kind of Chinese medicine composition for the treatment of breast carcinoma is characterized in that it mainly being to have following bulk drugs to make:
The complete old Fructus Trichosanthis 20-30 part of Radix Angelicae Sinensis 20-30 part Radix Glycyrrhizae 20-30 part
Olibanum (processed) 10-20 part Myrrha (processed) 10-20 part.
2, Chinese medicine composition according to claim 1, wherein preferred weight part of each crude drug is:
25 parts of 25 parts of complete old Fructus Trichosanthis of 25 parts of Radix Glycyrrhizae of Radix Angelicae Sinensis
15 parts of 15 parts of Myrrha (processed)s of Olibanum (processed).
3,, it is characterized in that in order to reach optimum curative effect, the yellow wine that can add 15 times of above composition total weight parts boils according to claim 1,2 described Chinese medicine compositions.
4,, it is characterized in that and to make any peroral dosage form with the conventional formulation method according to claim 1,2 described Chinese medicine compositions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510125223 CN1965888A (en) | 2005-11-19 | 2005-11-19 | Chinese medicinal composition for treating breast cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510125223 CN1965888A (en) | 2005-11-19 | 2005-11-19 | Chinese medicinal composition for treating breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1965888A true CN1965888A (en) | 2007-05-23 |
Family
ID=38074981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510125223 Pending CN1965888A (en) | 2005-11-19 | 2005-11-19 | Chinese medicinal composition for treating breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1965888A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585258A (en) * | 2013-10-18 | 2014-02-19 | 程广金 | Traditional Chinese medicine composition for treating breast pain |
| CN104771478A (en) * | 2015-04-17 | 2015-07-15 | 西安交通大学医学院第一附属医院 | Traditional Chinese medicine prescription for treating early mastitis and preparation method of externally applied drug coating based on traditional Chinese medicine prescription |
| CN116407576A (en) * | 2021-12-29 | 2023-07-11 | 北京同仁堂科技发展股份有限公司 | Pharmaceutical composition and application of preparation thereof in preparation of medicines for treating cancers |
-
2005
- 2005-11-19 CN CN 200510125223 patent/CN1965888A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103585258A (en) * | 2013-10-18 | 2014-02-19 | 程广金 | Traditional Chinese medicine composition for treating breast pain |
| CN104771478A (en) * | 2015-04-17 | 2015-07-15 | 西安交通大学医学院第一附属医院 | Traditional Chinese medicine prescription for treating early mastitis and preparation method of externally applied drug coating based on traditional Chinese medicine prescription |
| CN104771478B (en) * | 2015-04-17 | 2018-03-02 | 西安交通大学医学院第一附属医院 | A kind of preparation method of the Chinese medicinal formulae for being used to treat early stage mastitis and the external used medicine coating based on the Chinese medicinal formulae |
| CN116407576A (en) * | 2021-12-29 | 2023-07-11 | 北京同仁堂科技发展股份有限公司 | Pharmaceutical composition and application of preparation thereof in preparation of medicines for treating cancers |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN1265833C (en) | Chinese medicinal preparation for treating cancer | |
| CN1305515C (en) | Chinese medicine powder and decoction composition for treating cancers | |
| CN100462101C (en) | Medicament for treating aplastic anemia | |
| CN105535575A (en) | Medicament to reduce side effects of chemotherapy | |
| CN101062221A (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
| CN1965888A (en) | Chinese medicinal composition for treating breast cancer | |
| CN101757521B (en) | Traditional Chinese medicine for treating proliferation of mammary gland | |
| CN101530508A (en) | Traditional Chinese medicine for treating ovarian cancer | |
| CN1060657C (en) | Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method | |
| CN101259214B (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1843492A (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
| CN1410093A (en) | Medicine for treating cyst | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN103191369A (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN100341563C (en) | Chinese medicinal capsule for treating metrorrhagia and metrostaxis | |
| CN1290541C (en) | Medicinal extract for tonifying kidney and enriching blood made from foetal fuzz, and its prepn. method | |
| CN101088555A (en) | Medicine prepn for inhibiting tumor angiogenesis and cancer cell and enhancing immunity | |
| CN112237621A (en) | Traditional Chinese medicine emulsifiable paste for treating hyperplasia of mammary glands and preparation method thereof | |
| CN1433802A (en) | Chinese medicine for treating tumor and cancer | |
| CN1226443A (en) | External used ointment for mammary cancer and preparing method thereof | |
| CN1118262A (en) | Compounded composition for cancers | |
| CN1325696A (en) | Breast pill or ointment for treating mastopathy and preparing process thereof | |
| CN115475226A (en) | Traditional Chinese medicine composition for treating non-small cell lung cancer with toxicity attenuation and synergism of docetaxel and cisplatin | |
| CN114452369A (en) | Traditional Chinese medicine composition for treating breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Lihui Document name: Notice of publication of application for patent for invention |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Lihui Document name: Notification before expiration of term |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Lihui Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |